NECLIFE.NS · Nectar Lifesciences Limited
India · RS rating 18 · As of 2026-10-14
| Price | 10.16 INR |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 13 / 48 / 27 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 17 / 38 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +76.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +54.3% |
| Market cap (USD) | $20.7M |